Pyxis Oncology
PYXS
Pyxis Oncology (PYXS) news
Recent news
Pyxis Oncology, Inc.: Wells Fargo initiates coverage with overweight rating and target price $12
AInvest Wire · Aug 3, 2026Pyxis Oncology - sells 19.6 mln shares at $2.55 each with warrants at $3.29 exercise price
AInvest Wire · Jun 30, 2026Pyxis Oncology: financing led by BVF Partners L.P. with participation from GordonMD Global Investments, RTW Investments & Coastlands Capital
AInvest Wire · Jun 30, 2026Pyxis Oncology - upfront proceeds expected to extend cash runway into Q2 2027
AInvest Wire · Jun 30, 2026Pyxis Oncology announces up to $114M placement financing
Pyxis Oncology has announced a placement financing deal that could raise up to $114 million, according to recent disclosures. The financing is intended to support the company’s ongoing clinical development programs and operational needs as it advances its pipeline of oncology therapeutics. The…
AInvest Wire · Jun 30, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.